These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30127633)

  • 41. [A whole family affected by xeroderma pigmentosum: clinical and genetic particularities].
    Zghal M; Fazaa B; Zghal A; Mokhtar I; Sarasin A; Kamoun MR; Gharbi MR
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):31-6. PubMed ID: 12605154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them.
    Itoh T; Linn S; Ono T; Yamaizumi M
    J Invest Dermatol; 2000 May; 114(5):1022-9. PubMed ID: 10771487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice.
    Miyauchi-Hashimoto H; Okamoto H; Tanaka K; Horio T
    J Invest Dermatol; 1999 Jun; 112(6):965-70. PubMed ID: 10383746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group.
    Yarosh D; Klein J; O'Connor A; Hawk J; Rafal E; Wolf P
    Lancet; 2001 Mar; 357(9260):926-9. PubMed ID: 11289350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
    Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
    Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
    Martens MC; Emmert S; Boeckmann L
    Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Xeroderma pigmentosum clinical practice guidelines.
    Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
    J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant melanoma of the iris in xeroderma pigmentosum.
    Johnson MW; Skuta GL; Kincaid MC; Nelson CC; Wolter JR
    Arch Ophthalmol; 1989 Mar; 107(3):402-7. PubMed ID: 2923565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA repair deficient photodermatoses.
    Lehmann AR; Norris PG
    Semin Dermatol; 1990 Mar; 9(1):55-62. PubMed ID: 2203444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Squamous Cell Carcinoma in African Children with Xeroderma Pigmentosum: Three Case Reports.
    Kaloga M; Dioussé P; Diatta BA; Bammo M; Kourouma S; Diabate A; Gueye N; Dione H; Diallo M; Diop BM
    Case Rep Dermatol; 2016; 8(3):311-318. PubMed ID: 27920683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Xeroderma pigmentosum with repeated facial skin carcinogenesis: report of one case].
    Li F; Jiang YH; Zhan SL
    Shanghai Kou Qiang Yi Xue; 2012 Aug; 21(4):478-80. PubMed ID: 23135130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes.
    Itin PH; Sarasin A; Pittelkow MR
    J Am Acad Dermatol; 2001 Jun; 44(6):891-920; quiz 921-4. PubMed ID: 11369901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
    Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
    Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anesthetic management of a patient with xeroderma pigmentosum].
    Soen M; Kagawa T; Uokawa R; Suzuki T
    Masui; 2006 Feb; 55(2):215-7. PubMed ID: 16491904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xeroderma pigmentosum.
    Lambert WC; Kuo HR; Lambert MW
    Dermatol Clin; 1995 Jan; 13(1):169-209. PubMed ID: 7712643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Xeroderma pigmentosum and pigmented xerodermoid.
    Jung EG; Bantle K
    Birth Defects Orig Artic Ser; 1971 Jun; 7(8):125-8. PubMed ID: 5173256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.